Attorney General Accuses INSYS of Deceptively Marketing and Selling Its Opioid Painkiller
Illinois' attorney general on Thursday sued Insys Therapeutics Inc, accusing it of deceptively marketing and selling an addictive fentanyl-based medication, intended to treat cancer pain, to doctors for off-label uses.
The lawsuit, filed by Attorney General Lisa Madigan in Cook County Circuit Court, comes as Insys faces a number of state and investigations involving its drug Subsys as U.S. authorities seek to combat a national opioid abuse epidemic.
"This drug company's desire for increased profits led it to disregard patients' health and push addictive opioids for non-FDA approved purposes," Madigan said in a statement.
The lawsuit, filed by Attorney General Lisa Madigan in Cook County Circuit Court, comes as Insys faces a number of state and investigations involving its drug Subsys as U.S. authorities seek to combat a national opioid abuse epidemic.
"This drug company's desire for increased profits led it to disregard patients' health and push addictive opioids for non-FDA approved purposes," Madigan said in a statement.